Mark Lee

Mr. Lee focuses on HUTCHMED's strategic management, corporate operations, investor relations, and supporting its numerous R&D alliances. This includes leading or assisting with the project management of certain clinical programs, coordination of R&D leadership, and R&D financial management.

Prior to joining the company in 2009, Mr. Lee was with Credit Suisse in the United States and Europe, where he was involved in the execution and origination of mergers, acquisitions, public and private financings, and corporate strategy for pharmaceutical, life science, and healthcare companies such as AstraZeneca, Bristol-Myers Squibb, Genzyme, and Syngenta, amongst others.

Mr. Lee received his Bachelor of Engineering in Biochemical Engineering with First Class Honours from University College London, where he was awarded a Dean’s Commendation. He also received a Master of Business Administration from the Massachusetts Institute of Technology, Sloan School of Management.